BCL2 gene: Current relevance to clinical oncology
- 1 January 1992
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (1) , 270-272
- https://doi.org/10.1016/0959-8049(92)90431-z
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- A genotypic study of low grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT)The Journal of Pathology, 1990
- Small G proteins are expressed ubiquitously in lymphoid cells and do not correspond to Bcl-2Nature, 1990
- The bcl-2 Gene, Follicular Lymphoma, and Hodgkin's DiseaseJNCI Journal of the National Cancer Institute, 1990
- Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1990
- The bcl-2 gene encodes a novel G proteinNature, 1989
- bcl-2and Other Genomic Alterations in the Prognosis of Large-Cell LymphomaNew England Journal of Medicine, 1989
- Multiple Recurrent Genomic Defects in Follicular LymphomaNew England Journal of Medicine, 1987
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1982